|
| 36095039 | Disentangling self from pain: mindfulness meditation-induced pain relief is driven by thalamic-default mode network decoupling. | Pain | 2023 |
| 37021132 | Editorial: Current advances in the study of Down Syndrome: From development to aging. | Front Neurosci | 2023 |
| 37449271 | Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior. | Front Neurosci | 2023 |
| 37042072 | Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ-Secretase Modulator. | Ann Neurol | 2023 |
| 37428606 | Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain. | Annu Rev Neurosci | 2023 |
| 36370135 | Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose. | Alzheimers Dement | 2023 |
| 34757693 | Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. | Alzheimers Dement | 2022 |
| 35532913 | Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial. | JAMA Neurol | 2022 |
| 35957650 | Learning to Practice Compassionate Care: Medical Students Discuss Their Most Memorable Lessons. | J Patient Exp | 2022 |
| 34990205 | Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders. | Annu Rev Pharmacol Toxicol | 2022 |
| 32618475 | Minocycline Topical Foam: A New Drug for the Treatment of Acne. | Ann Pharmacother | 2021 |
| 33651103 | Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention. | J Exp Med | 2021 |
| 33924960 | Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. | J Clin Med | 2021 |
| 33729670 | Specialty clinics for adults with Down syndrome: A clinic survey. | Am J Med Genet A | 2021 |
| 33691783 | Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport. | Alzheimers Res Ther | 2021 |
| 33660221 | Specific Susceptibility to COVID-19 in Adults with Down Syndrome. | Neuromolecular Med | 2021 |
| 34421499 | Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society. | Mol Syndromol | 2021 |
| 34276349 | Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome. | Front Aging Neurosci | 2021 |
| 34248930 | Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. | Front Immunol | 2021 |
| 34268067 | Opportunities, barriers, and recommendations in down syndrome research. | Transl Sci Rare Dis | 2021 |
| 33948879 | Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome. | Neuromolecular Med | 2021 |
| 32975365 | Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. | Alzheimers Dement | 2021 |
| 32544310 | Further understanding the connection between Alzheimer's disease and Down syndrome. | Alzheimers Dement | 2020 |
| 31980301 | Enabling Technologies for Personalized and Precision Medicine. | Trends Biotechnol | 2020 |
| 33288820 | Detailed evaluation of the upper airway in the Dp(16)1Yey mouse model of Down syndrome. | Sci Rep | 2020 |
| 33007551 | Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators. | Bioorg Med Chem | 2020 |
| 32974736 | Editorial for the special issue neurotrophic factors. | Cell Tissue Res | 2020 |
| 32601248 | Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor/ERK Signaling Axis. | J Neurosci | 2020 |
| 32936344 | Local TrkB signaling: themes in development and neural plasticity. | Cell Tissue Res | 2020 |
| 32724206 | Author Correction: Reversing a model of Parkinson's disease with in situ converted nigral neurons. | Nature | 2020 |
| 32581380 | Reversing a model of Parkinson's disease with in situ converted nigral neurons. | Nature | 2020 |
| 32281945 | (H)Elping nerve growth factor: Elp1 inhibits TrkA's phosphatase to maintain retrograde signaling. | J Clin Invest | 2020 |
| 31133787 | Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses. | Front Neurosci | 2019 |
| 31753140 | Down syndrome. | Handb Clin Neurol | 2019 |
| 31293377 | Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species. | Front Neurosci | 2019 |
| 29031834 | Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. | Free Radic Biol Med | 2018 |
| 30120810 | T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation. | Traffic | 2018 |
| 29609879 | Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014. | Clin Ther | 2018 |
| 29576115 | Inhibition of RhoA reduces propofol-mediated growth cone collapse, axonal transport impairment, loss of synaptic connectivity, and behavioural deficits. | Br J Anaesth | 2018 |
| 29483280 | Swedish Nerve Growth Factor Mutation (NGF<sup>R100W</sup>) Defines a Role for TrkA and p75<sup>NTR</sup> in Nociception. | J Neurosci | 2018 |
| 28587118 | Nerve Growth Factor and Related Substances: A Brief History and an Introduction to the International NGF Meeting Series. | Int J Mol Sci | 2017 |
| 28342823 | Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome. | Neurobiol Dis | 2017 |
| 28416568 | Pharmacological and Toxicological Properties of the Potent Oral <i>γ</i>-Secretase Modulator BPN-15606. | J Pharmacol Exp Ther | 2017 |
| 28946567 | PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI). | J Alzheimers Dis | 2017 |
| 27023444 | An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome. | PLoS One | 2016 |
| 28642933 | Dissociation of Down syndrome and Alzheimer's disease effects with imaging. | Alzheimers Dement (N Y) | 2016 |
| 27701794 | GABAergic hyperinnervation of dentate granule cells in the Ts65Dn mouse model of down syndrome: Exploring the role of App. | Hippocampus | 2016 |
| 27789459 | Mouse-based genetic modeling and analysis of Down syndrome. | Br Med Bull | 2016 |
| 27601642 | TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease. | Proc Natl Acad Sci U S A | 2016 |
| 27998093 | Cucurbit[7]uril-Tetramethylrhodamine Conjugate for Direct Sensing and Cellular Imaging. | J Am Chem Soc | 2016 |